Skip to Main Content

Archives

01.14.21

India Must Have Vaccine Transparency for the World’s Largest Immunization Program to Succeed

By O’Neill Institute

This expert column was written by Kashish Aneja.  On January 16, India is set to launch the world’s largest national immunization programme with two of its ‘made in India’ vaccines. India sits at the center of the COVID-19 response, not just because it has the second-highest number of global cases, or only due to its […]

Tags:

11.30.20

HIV Policies In Most Countries Are Not Aligned With International Standards, Undermining Progress Against AIDS, New Report Shows

By Cynthia Sun

FOR IMMEDIATE RELEASE  November 30, 2020 Washington, DC — With the global AIDS response set to miss 2020 targets and COVID-19 threatening to derail progress, a new report today shows that many countries have not adopted key policies needed to take advantage of scientific breakthroughs in HIV. The science of HIV has never been better, […]

Tags:

10.20.20

Leading the COVID-19 Vaccination Response: Lessons Learned from the Smallpox Eradication Campaign

By O’Neill Institute

This expert column was written by Adi Radhakrishnan.  With more than 40 million known cases worldwide, and many countries already experiencing a second surge, the global recovery from COVID-19 still appears far away. Experts recently forecast that that the full course of the pandemic will likely run for two years and will only subside if […]

Tags:

09.29.20

New HIV Policy Lab uses law and policy data in the HIV response

By Cynthia Sun

FOR IMMEDIATE RELEASE 29 September 2020 WASHINGTON/GENEVA—Despite decades of scientific advances in the HIV response, progress remains uneven, with some countries rapidly reducing AIDS-related deaths and new HIV infections and others seeing increasing epidemics. Laws and policies are driving a significant part of that divergence.  Launched today, the HIV Policy Lab is a unique initiative to gather and monitor […]

Tags:

08.24.20

COVID-19 in 2021: What Lies Ahead?

By Cynthia Sun

The 2020 O’Neill Institute for National and Global Health Law Colloquium begins this year’s series by reflecting on the greatest public health emergency of the century–the COVID-19 pandemic. COVID-19 has infected over 20 million globally, and taken nearly a million lives. From social distancing, mask requirements, and the shift to virtual learning and work environments, […]

Categories:
Tags:

08.20.20

Q&A with Kashish Aneja

By O’Neill Institute

Kashish Aneja is a practicing lawyer in New Delhi, and an international legal consultant specializing in Global Health Law. Currently, he’s consulting for the O’Neill Institute, and over the past 2 years, he worked in different capacities for the World Health Organization (WHO), Centre for Reproductive Rights and GAVI the Vaccine Alliance. 1. What drew […]

Tags:

08.03.20

Racially-Driven Police Violence is a Human Rights Violation

By Sarah Wetter

This post was written by Erica White, Intern, O’Neill Institute, and JD Candidate, ASU Law; and Sarah Wetter, Law Fellow, O’Neill Institute. On June 15, 2020 the United Nations Human Rights Council convened for the first time after a three-month long hiatus necessitated by the COVID-19 pandemic. The Council focused on a major threat to […]

07.27.20

A Post-COVID-19 Global Health Infrastructure, Part II: Health Equity Programs of Action

By Eric A. Friedman

  Today’s existing global health arrangements failed to stop COVID-19 from so far infecting more than 16 million people – and fast rising – and killing more than 600,000 – a toll rising by thousands every day, and with both infections and deaths likely drastically underreported. Of course, even before COVID-19, the global heath infrastructure […]

07.14.20

A wolf in sheep’s clothing: the food and beverage industry and our ability to respond to health challenges

By Isabel Barbosa

Image courtesy of the New York-Presbyterian/Weill Cornell Genitourinary (GU) Oncology Program Since the Covid-19 pandemic took over the world, the food and beverage industry has been raising its profile by engaging in highly publicized donations. Last month, for example, Coca-Cola announced that they were “supporting communities and health professionals” by “donating over 2.5 million liters […]

Categories:
Tags:

The views reflected in this expert column are those of the individual authors and do not necessarily represent those of the O’Neill Institute for National and Global Health Law or Georgetown University. This blog is solely informational in nature, and not intended as a substitute for competent legal advice from a licensed and retained attorney in your state or country.

See the full disclaimer and terms of use.